Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.
Herman GA, O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Musser BJ, Davis JD, Turner KC, Mahmood A, Hooper AT, Hamilton JD, Parrino J, Subramaniam D, Baum A, Kyratsous CA, DiCioccio AT, Stahl N, Braunstein N, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team. Herman GA, et al. Among authors: cohen ms. Lancet Infect Dis. 2022 Oct;22(10):1444-1454. doi: 10.1016/S1473-3099(22)00416-9. Epub 2022 Jul 5. Lancet Infect Dis. 2022. PMID: 35803290 Free PMC article. Clinical Trial.
Does ART prevent HIV transmission among MSM?
Muessig KE, Smith MK, Powers KA, Lo YR, Burns DN, Grulich AE, Phillips AN, Cohen MS. Muessig KE, et al. Among authors: cohen ms. AIDS. 2012 Nov 28;26(18):2267-73. doi: 10.1097/QAD.0b013e328355713d. AIDS. 2012. PMID: 22569019 Free PMC article. Review.
Investigating a sexual network of black men who have sex with men: implications for transmission and prevention of HIV infection in the United States.
Hurt CB, Beagle S, Leone PA, Sugarbaker A, Pike E, Kuruc J, Foust EM, Eron JJ Jr, Cohen MS, Hightow-Weidman LB. Hurt CB, et al. Among authors: cohen ms. J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):515-21. doi: 10.1097/QAI.0b013e31827076a4. J Acquir Immune Defic Syndr. 2012. PMID: 22972020 Free PMC article.
HIV prevention: great achievements, more challenges ahead.
El-Sadr WM, Serwadda DM, Sista N, Cohen MS. El-Sadr WM, et al. Among authors: cohen ms. J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2(0 2):S115-6. doi: 10.1097/QAI.0b013e318299c3d9. J Acquir Immune Defic Syndr. 2013. PMID: 23764621 Free PMC article. No abstract available.
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.
Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, Wang L, Ou SS, Anderson M, McCauley M, Gamble T, Kumarasamy N, Hakim JG, Kumwenda J, Pilotto JH, Godbole SV, Chariyalertsak S, de Melo MG, Mayer KH, Eshleman SH, Piwowar-Manning E, Makhema J, Mills LA, Panchia R, Sanne I, Gallant J, Hoffman I, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Havlir D, Cohen MS; HPTN 052-ACTG Study Team. Grinsztejn B, et al. Among authors: cohen ms. Lancet Infect Dis. 2014 Apr;14(4):281-90. doi: 10.1016/S1473-3099(13)70692-3. Epub 2014 Mar 4. Lancet Infect Dis. 2014. PMID: 24602844 Free PMC article. Clinical Trial.
Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials.
Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, Wang J, Eshleman SH, Mayer KH, Magaret CA, Hural J, Kublin JG, Gray G, Montefiori DC, Gomez MM, Burns DN, McElrath J, Ledgerwood J, Graham BS, Mascola JR, Cohen M, Corey L. Gilbert PB, et al. Stat Commun Infect Dis. 2017 Jan;9(1):20160001. doi: 10.1515/scid-2016-0001. Epub 2017 Jun 6. Stat Commun Infect Dis. 2017. PMID: 29218117 Free PMC article.
1,355 results